We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

This study is currently recruiting participants.
Verified July 2016 by Chinese Pulmonary Vascular Disease Research Group
Sponsor:
ClinicalTrials.gov Identifier:
NCT02214043
First Posted: August 12, 2014
Last Update Posted: July 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Chinese Pulmonary Vascular Disease Research Group
  Purpose
There are no special clinical characteristics of acute pulmonary embolism in Chinese population.

Condition
Pulmonary Embolism

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

Resource links provided by NLM:


Further study details as provided by Chinese Pulmonary Vascular Disease Research Group:

Primary Outcome Measures:
  • The primary end point of the present study was symptomatic, objectively confirmed recurrent fatal or nonfatal VTE. [ Time Frame: 60 months ]

Secondary Outcome Measures:
  • The second end point was death (all cause death and PE-related death). [ Time Frame: 60 months ]
    If the participant died, the relatives need provided the written medical record on the death.


Biospecimen Retention:   Samples Without DNA
BNP,D-dimer

Estimated Enrollment: 600
Study Start Date: January 2012
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
Group 2
group 1

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Acute pulmonary embolism in Chinese population
Criteria

Inclusion Criteria:

  • the symptomatic acute PE confirmed by objective examination

Exclusion Criteria:

  • congestive heart failure
  • chronic obstructive pulmonary disease;
  • a prior documented episode of PE or DVT
  • renal dysfunction;
  • a life expectancy of less than 6 months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02214043


Contacts
Contact: Zhihong Liu, Doctor 8601088396590 Zhihongliufuwai@163.com

Locations
China
Center of pumonary vascular diseases Recruiting
Beijing, China, 100037
Contact: Zhihong Liu, doctor    8601088396591    zhihongliufuwai@163.com   
Sponsors and Collaborators
Chinese Pulmonary Vascular Disease Research Group
Investigators
Study Chair: Zhihong Liu, Doctor Chinese pulmonary vascular disease organization group
  More Information

Responsible Party: Chinese Pulmonary Vascular Disease Research Group
ClinicalTrials.gov Identifier: NCT02214043     History of Changes
Other Study ID Numbers: APEINCP
First Submitted: February 3, 2014
First Posted: August 12, 2014
Last Update Posted: July 21, 2017
Last Verified: July 2016

Additional relevant MeSH terms:
Embolism
Pulmonary Embolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases